Casper Mountain Rehab: 12 Deficiencies Found - WY
The August inspection revealed that staff couldn't locate critical documentation for residents taking powerful antipsychotic and antianxiety drugs, medications that federal regulations require nursing homes to minimize and regularly evaluate.
Resident 9, diagnosed with schizophrenia, was prescribed quetiapine fumarate and buspirone hydrochloride for paranoid schizophrenia. The facility's own records showed the last risk-benefit statement was completed nearly a year earlier on September 17, 2024, but staff couldn't produce the physician-signed document when inspectors requested it.
The resident's quarterly assessment in March indicated a gradual dose reduction had been attempted on December 31, 2024. Staff couldn't find that documentation either.
"The interim DON revealed she was currently working on organizing the psychotropic medication review process," inspectors wrote after interviewing the director of nursing.
More troubling was a standing order for lorazepam, a potent antianxiety medication, prescribed for the resident's "comfort focused care" on August 1. The order had no stop date, violating federal requirements that such medications be time-limited. Records showed the resident hadn't received any doses of the drug during August, raising questions about why it remained prescribed.
The interim director of nursing confirmed during a second interview that afternoon that the gradual dose reduction documentation for Resident 9 "could not be located."
Resident 98 faced a different problem. Admitted with depression, the person was prescribed 100 milligrams of Sertraline daily in January 2024. Federal law requires nursing homes to attempt gradual dose reductions of antidepressants unless clinically contraindicated.
No reduction was ever attempted.
The resident's June quarterly assessment showed they were receiving both antipsychotics and antidepressants, but marked that no gradual dose reduction had been tried and none was documented as clinically contraindicated. A medication review signed by the physician in October 2024 showed no reduction was ordered and provided no clinical rationale for continuing the current dose.
"No GDR was attempted and no rationale was documented for the resident," the interim director of nursing told inspectors.
The violations highlight a broader pattern of medication management failures at the facility. Federal regulations require nursing homes to ensure residents are free from unnecessary drugs, particularly psychiatric medications that can cause sedation, falls, and other serious side effects in elderly patients.
Antipsychotic medications carry particular risks for nursing home residents, including increased mortality rates and cognitive decline. The drugs are often prescribed inappropriately for behavioral symptoms of dementia, leading to federal initiatives to reduce their use in long-term care facilities.
The facility's psychotropic medication utilization report from August showed both residents continued receiving multiple psychiatric drugs despite the missing documentation and lack of required reviews.
Gradual dose reductions are a cornerstone of federal medication safety requirements. Nursing homes must attempt to reduce psychiatric medications unless a physician documents specific clinical reasons why reduction would be harmful. The process helps identify residents who may no longer need the drugs or could function safely on lower doses.
The inspection found the facility's interim director of nursing was "currently working on organizing the psychotropic medication review process," suggesting systemic problems with medication oversight extended beyond the two residents cited.
Federal inspectors classified the violations as causing minimal harm or potential for actual harm to residents, affecting few people. However, the missing documentation and lack of required medication reviews represent fundamental failures in resident safety protections.
The findings raise questions about how many other residents at Casper Mountain Rehabilitation may be receiving unnecessary psychiatric medications without proper physician oversight or required safety evaluations.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Casper Mountain Rehabilitation and Care Center from 2025-08-27 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
Casper Mountain Rehabilitation and Care Center in Casper, WY was cited for violations during a health inspection on August 27, 2025.
Resident 9, diagnosed with schizophrenia, was prescribed quetiapine fumarate and buspirone hydrochloride for paranoid schizophrenia.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.